For example, the number of clinical samples was insufficient (only 74 cases), which did not fully explain the effect of NTF3 on tumor staging, tumor size, liver cirrhosis, lymph node metastasis and other clinicopathological indicators. This evidence concerns the gene NTF3 and metastatic malignant neoplasm in the lymph nodes.